"In order to win and outcompete China, the U.S. needs to lead in AI, quantum, and biotech." This declaration from former Commerce Secretary Gina Raimondo, speaking with CNBC's "Squawk Box," sets a clear strategic imperative for the United States. Her participation in a discussion about a new bipartisan report from the Council on Foreign Relations on economic security and strategic competition in emerging technologies highlights the critical juncture at which the nation finds itself. The report underscores that the technological race with China is not merely about economic advantage, but fundamental national security.
Raimondo emphasized the urgency of the situation, noting that while bipartisan agreement is rare these days, the report's findings on economic security and competition in emerging technologies resonated across the political spectrum. This consensus is crucial, as the United States faces significant challenges in maintaining its technological edge, particularly against China's aggressive advancements. The report, which Raimondo co-chaired, identifies AI, quantum computing, and biotechnology as the key battlegrounds where this competition is being waged.
A core insight from Raimondo's commentary is the direct link between technological leadership and national security. She stated, "We really need to lead in AI, quantum, and biotechnology. That means everything from staying ahead, you know, out-innovating faster than China, but also securing our supply chains." This dual focus on innovation and supply chain resilience is paramount. The pandemic exposed vulnerabilities in global supply chains, and the report aims to address how the U.S. can bolster its domestic capacity in critical technology sectors to mitigate risks and ensure national security.
The discussion also touched upon the effectiveness of current trade policies, particularly tariffs. Raimondo acknowledged that while tariffs can be a tool, they are not a panacea. She indicated that the effectiveness of such measures is often debated, and that a broader strategy is required. This implies a need for more nuanced approaches that foster domestic innovation and strengthen alliances, rather than relying solely on punitive measures.
A significant concern raised was the extent of China's investment and focus on these critical technologies. Raimondo highlighted that "China is obsessively focused. The PRC has increased its investment in biotech by 400x in the past 10 years." This staggering figure underscores the scale of China's commitment and the potential for them to gain a decisive advantage if the U.S. does not respond with commensurate urgency and investment. The report’s findings suggest that the U.S. must not only invest but also ensure that its innovations and supply chains are secure and not overly reliant on adversarial nations.
